Robert Sexton

Robert Sexton is a seasoned legal and business executive with extensive experience in the biopharmaceutical and healthcare sectors. Currently serving as a Board Member for PVP Therapeutics AG and Dioun Health, Sexton brings significant expertise in corporate governance and strategic oversight. Previously, Sexton held the position of VP & General Counsel, International at Amgen, overseeing legal matters outside the United States and managing M&A transactions. Early career highlights include a partnership at Salans (now Dentons LLP), leading corporate/M&A practices, and a role as an attorney at Kirkland & Ellis. Educational credentials include a J.D., magna cum laude from The Catholic University of America, and an Executive Certificate in Venture Capital from Imperial College London Business School, along with degrees from the University of Virginia.